Amplius Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$816K Buy
3,241
+897
+38% +$193K 0.06% 87
2026
Q1
$510K Buy
2,344
+5
+0.2% +$1.11K 0.04% 103
2025
Q4
$534K Sell
2,339
-323
-12% -$73.6K 0.04% 103
2025
Q3
$616K Sell
2,662
-178
-6% -$36.2K 0.05% 94
2025
Q2
$527K Buy
2,840
+26
+0.9% +$4.83K 0.05% 114
2025
Q1
$590K Buy
2,814
+237
+9% +$46.1K 0.06% 103
2024
Q4
$458K Sell
2,577
-21
-0.8% -$3.86K 0.05% 116
2024
Q3
$513K Hold
2,598
0.06% 96
2024
Q2
$446K Sell
2,598
-29
-1% -$4.8K 0.05% 104
2024
Q1
$478K Sell
2,627
-41
-2% -$7.07K 0.05% 101
2023
Q4
$413K Buy
2,668
+400
+18% +$58.3K 0.05% 108
2023
Q3
$338K Sell
2,268
-59
-3% -$8.66K 0.05% 112
2023
Q2
$314K Sell
2,327
-457
-16% -$67K 0.04% 121
2023
Q1
$444K Buy
2,784
+1,055
+61% +$161K 0.06% 106
2022
Q4
$279K Sell
1,729
-3,570
-67% -$547K 0.04% 124
2022
Q3
$711K Buy
5,299
+93
+2% +$13.3K 0.13% 68
2022
Q2
$797K Sell
5,206
-796
-13% -$122K 0.13% 67
2022
Q1
$972K Sell
6,002
-2,345
-28% -$341K 0.15% 65
2021
Q4
$1.13M Buy
+8,347
New +$986K 0.16% 64

Other funds holding ABBV

Amplius Wealth Advisors's ABBV Position: Q2 2026 in Review

Amplius Wealth Advisors increased its AbbVie (ABBV) stake by 38% in Q2 2026, buying an estimated $193K and bringing the position to 3,241 shares worth $816K. The position accounts for 0.06% of the portfolio, ranked #87.

Amplius Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.13M in Q4 2021. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Amplius Wealth Advisors held 3,241 shares of AbbVie worth $816K as of Q2 2026.
  • Amplius Wealth Advisors bought 897 AbbVie shares in Q2 2026, an estimated $193K.
  • AbbVie made up 0.06% of Amplius Wealth Advisors's portfolio in Q2 2026, its #87 holding.
  • Amplius Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Amplius Wealth Advisors's AbbVie position peaked at $1.13M in Q4 2021.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Amplius Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.